~~<i id='BDE8D87D1D'><strike id='BDE8D87D1D'><tt id='BDE8D87D1D'><pre id='BDE8D87D1D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：explore 2025-09-30 07:38:46 - browse：9657

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： What will save rural psychiatry services? Higher Medicaid payments

hotspot

focus

leisure time

focus

BGIGrouphasbeentargetedbyadarkmoneygroupsupportingtheBIOSECUREAct.STR/AFPviaGettyImagesYou’rereading

WSS

Achieving telehealth equity for people with hearing loss

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

The world needs the new pandemic treaty

Latest bird flu infection made farmworker sicker than earlier cases

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Do more moles mean more problems? Not so, says new study

focus

focus

Featured Speakers

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Akili, maker of video game for ADHD, to be acquired for 34 million

In age of alternative facts, a scholarly course on calling out crap

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lab trade group sues FDA to halt regulation of lab

Guidelines to prevent youth baseball injuries need more muscle

Biohaven protein

Duchenne breakthrough therapy leaves behind pioneering families

Focused ultrasound for uterine fibroids: an uphill battle

hotspot

Do more moles mean more problems? Not so, says new study

U.S. death rates show how politics are affecting public health

Louisiana bill approved classifying abortion pills as controlled substances

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Average age of first period drops to 11.9 years, study shows

Hospitals need to get ahead of regulations on climate change

focus

focus

leisure time

focus